The NIA is committed to determining the causes of AD so that more effective therapies can be developed to treat people with this devastating disorder. To help identify the genes that play a role in the development of AD, the NIA has funded NCRAD as a national resource where clinical information and biological material (DNA, plasma, serum, RNA and brain tissue) can be stored from individuals with AD as well as from individuals without any symptoms of memory loss or dementia.

To help identify the genes contributing to the risk for AD, a number of different studies are currently ongoing. These include studies enrolling families with multiple members diagnosed with AD, as well as individuals without a strong family history of AD.

NCRAD collects and maintains biological specimens and associated data on large numbers of genetically informative, phenotypically well-characterized families with multiple individuals affected with Alzheimer's disease, as well as individuals for case-control studies. Qualified research scientists may apply to NCRAD for samples and data to conduct genetic research.

NIA has in place a Genetics Initiative to assist in the identification of the risk factor genes for Alzheimer's disease. To this end, NIA supports the National Cell Repository for Alzheimer's Disease (NCRAD) at Indiana University as a national repository in order to facilitate access by qualified investigators to samples and Associated Phenotypic Data for the study of the genetics of late-onset Alzheimer's disease. Therefore it is the policy of the NIA that useful specimens and Associated Phenotypic Data for the genetics of late-onset Alzheimer's disease be deposited at NCRAD whenever possible. Qualified investigators will be able to use biological samples and Associated Phenotypic Data supplied by NCRAD. Application for use will be made directly to NCRAD.

Associated Phenotypic Data is defined as deidentified data on family structure, age, sex, vital status, psychopathology, diagnosis, and other clinically relevant associated phenotypic information, stripped of all personal identifiers and thus unlinkable to the individuals from whom they were obtained. To help identify the genes contributing to the risk for Alzheimer's disease, a number of different studies are currently ongoing. These include studies enrolling families with multiple members diagnosed with Alzheimer's disease as well as individuals without a strong family history of Alzheimer's disease.

The NIA is committed to determining the causes of AD so that more effective therapies can be developed to treat people with this devastating disorder. To help identify the genes that play a role in the development of AD, the NIA has funded NCRAD as a national resource where clinical information and biological material (DNA, plasma, serum, RNA and brain tissue) can be stored from individuals with AD as well as from individuals without any symptoms of memory loss or dementia.

To help identify the genes contributing to the risk for AD, a number of different studies are currently ongoing. These include studies enrolling families with multiple members diagnosed with AD, as well as individuals without a strong family history of AD.

NCRAD collects and maintains biological specimens and associated data on large numbers of genetically informative, phenotypically well-characterized families with multiple individuals affected with Alzheimer's disease, as well as individuals for case-control studies. Qualified research scientists may apply to NCRAD for samples and data to conduct genetic research.

NIA has in place a Genetics Initiative to assist in the identification of the risk factor genes for Alzheimer's disease. To this end, NIA supports the National Cell Repository for Alzheimer's Disease (NCRAD) at Indiana University as a national repository in order to facilitate access by qualified investigators to samples and Associated Phenotypic Data for the study of the genetics of late-onset Alzheimer's disease. Therefore it is the policy of the NIA that useful specimens and Associated Phenotypic Data for the genetics of late-onset Alzheimer's disease be deposited at NCRAD whenever possible. Qualified investigators will be able to use biological samples and Associated Phenotypic Data supplied by NCRAD. Application for use will be made directly to NCRAD.

Associated Phenotypic Data is defined as deidentified data on family structure, age, sex, vital status, psychopathology, diagnosis, and other clinically relevant associated phenotypic information, stripped of all personal identifiers and thus unlinkable to the individuals from whom they were obtained. To help identify the genes contributing to the risk for Alzheimer's disease, a number of different studies are currently ongoing. These include studies enrolling families with multiple members diagnosed with Alzheimer's disease as well as individuals without a strong family history of Alzheimer's disease.